Human Immunodeficiency Virus Clinical Trial
Official title:
Feasibility and Acceptability of an Intervention to Optimize Retention in Care and Adherence to Anti-retroviral Therapy Amongst Adolescents Living With HIV in Rwanda
HIV has now become the leading cause of death amongst adolescents in Africa with over 2.1
million adolescents (aged 10-19 years old) living with HIV today. Poor adherence to
anti-retroviral therapy (ART) leads to suppressed immune function, treatment failure,
increased morbidity and mortality with significant costs to households and health systems.
The investigators aim to undertake a feasibility study of an intervention targeting
adolescents living with HIV in Rwanda built on two components.
1. Life-skills training: Adolescents receive training on economic empowerment, financial
literacy, healthy relationships and adherence during the peer group sessions.
2. Financial incentives: Combined short-term and long-term incentives for clinic attendance
and suppressed viral load that will be delivered through mobile banking.
HIV has now become the leading cause of death amongst adolescents in Africa with over 2.1
million adolescents (aged 10-19 years old) living with HIV today. Increased mortality amongst
HIV-infected adolescents is primarily caused by poor adherence to anti-retroviral therapy
(ART). Adherence to ART is critical to suppress HIV viral load, sustain immune function, and
avoid opportunistic infections and death. Poor adherence leads to suppressed immune function,
treatment failure, increased morbidity and mortality with significant costs to households and
health systems. In our clinic population in Rwanda, 29% of 12-19 years olds have a
non-suppressed viral load due to poor adherence. These findings have been reflected in
studies throughout the US, Europe and sub-Saharan Africa.
The evidence base for effective adherence interventions that successfully address the
multiple barriers to adherence is very limited. Conditional cash transfers have shown promise
as a potential strategy. The investigators aim to undertake a feasibility study of an
intervention targeting adolescents living with HIV in Rwanda built on two components.
1. Life-skills training: Adolescents receive training on economic empowerment, financial
literacy, healthy relationships and adherence during the peer group sessions.
2. Financial incentives: Combined short-term and long-term incentives for clinic attendance
and suppressed viral load that will be delivered through mobile banking. On admission to
the program adolescents are provided with a bank account. The rewards delivered to the
adolescent are divided into a long-term and short term component. The long-term
incentive accrues and can only be accessed on graduation from the program. The
short-term component can be accessed immediately.
The aim of this preliminary study is not to assess for efficacy of the intervention
(virological suppression and clinic attendance). This preliminary study aims to assess the
feasibility of the program and data collection strategy in preparation for a large scale
multi-center evaluation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03516318 -
Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria
|
N/A | |
Completed |
NCT04653194 -
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'
|
Phase 3 | |
Completed |
NCT01792570 -
DRV/r + RPV QD: Efficacy and Toxicity Reduction
|
Phase 3 | |
Active, not recruiting |
NCT04826562 -
Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)
|
Phase 4 | |
Completed |
NCT04191967 -
Thermocoagulation for Treatment of Precancerous Cervical Lesions
|
N/A | |
Completed |
NCT02812329 -
Intervention to Encourage HIV Testing and Counseling Among Adolescents
|
Phase 1 | |
Completed |
NCT02919306 -
Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults
|
Phase 1/Phase 2 | |
Completed |
NCT02516930 -
A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China
|
N/A | |
Completed |
NCT02651376 -
Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT02392884 -
HIV Medication Adherence in Underserved Populations
|
N/A | |
Completed |
NCT01944371 -
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
|
Phase 1/Phase 2 | |
Recruiting |
NCT01778374 -
Mater-Bronx Rapid HIV Testing Project.
|
N/A | |
Completed |
NCT00914225 -
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
|
N/A | |
Completed |
NCT01076179 -
Kaletra in Combination With Antiretroviral Agents
|
N/A | |
Completed |
NCT01490346 -
Tissue Drug Levels of HIV Medications
|
N/A | |
Completed |
NCT01460433 -
Problems With Immune Recovery in the Gut Tissue
|
N/A | |
Completed |
NCT00317460 -
Buprenorphine and Integrated HIV Care
|
Phase 4 | |
Terminated |
NCT04240210 -
Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)
|
Phase 4 | |
Active, not recruiting |
NCT04704336 -
Integration of Hypertension Management Into HIV Care in Nigeria
|
N/A | |
Completed |
NCT03254277 -
3BNC117-LS First-in-Human Phase 1 Study
|
Phase 1 |